Polymerase Chain Reaction (PCR) techniques have found increased application in pharmaceutical, biotechnology and life sciences industries. PCR is primarily used for developing assays, test kits & solutions, and culture media in the tissue culture industry. Adoption of this technique is the end result of important technological breakthroughs in the healthcare industry.
PCR is also used to determine the genesis of several chronic and infectious diseases. For instance, the technique was widely applied in 2015 for determining the outbreak of the Zika virus epidemic. Such increased applications are anticipated to double the revenue of the global demand for polymerase chain reaction (PCR) is Expanding at an anticipated CAGR of 8.4%, the global PCR market is set to surpass US$ 7 Bn mark by 2026.
For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4861
Global Polymerase Chain Reaction (PCR) Market: Segmentation
Product
- Instruments
- Standard PCR Systems
- RT PCR Systems
- Digital PCR Systems
- Reagents
- Consumables
End User
- Pharmaceutical & Biotechnology Industries
- Clinical Diagnostics Labs and Hospitals
- Academic and Research Organizations
- Others
Following Questions Answers Covered in the Report are:
- How will the global Polymerase Chain Reaction (PCR) Market perform during the forecast period? What will be the market size in terms of value and volume?
- Which segment will drive the global Polymerase Chain Reaction (PCR) Market? Which regional market will show extensive growth in the future? What are the reasons?
- How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
- What are the key strategies adopted by players to sustain themselves in the global Polymerase Chain Reaction (PCR) Market?
- How will these strategies influence the market growth and competition?
Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4861
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
- Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)
The Report Covers Exhaustive Analysis On:
- Market Segments
- Market Dynamics
- Market Size & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
COVID-19 Impact Analysis
With the number of coronavirus cases proliferating at an exponential rate, the need for COVID-19 testing has surged in the past few months. The most frequently employed testing method is the RT-PCR test, which provides a reliable estimate of the degree of infection within a patient. Due to the dearth of availability of alternative tests, the RT-PCR is gaining the upper hand in this regard, despite the fact that the time lag between the test and results is immensely large.
Market players specializing in the provision of RT-PCR testing kits are working towards enhancing the testing efficiency and providing timely results. For instance, Thermo Fisher Scientific is looking to maintain the geometric amplification of the target gene throughout the testing duration for better results. Presently, the geometric progression eventually transforms to a linear progression, thus reducing testing efficiency. Nevertheless, RT-PCR tests will continue to gain popularity in the duration of the pandemic.
R&D and Product Launches Remain Key Growth Catalysts of Market Players
The global PCR market is consolidated with leading players such as Roche Diagnostics, Abbott Laboratories and Thermo Fishers Scientific accounting for maximum market share. However, new entrants are finding a marketplace, owing to the introduction of advanced technologies.
F. Hoffmann La- Roche AG is the dominant market player, offering diverse products and solutions in various fields including clinical chemistry and immunoassay, molecular diagnostics, and tissue diagnostics. It specializes in the provision of real-time PCR and includes products such as Cobas S 201, Cobas TaqScreen MPX Test, Cobas 4800 System and Light Cylinder MRSA Advanced Test.
Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4861
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Jumeirah Lakes Towers,
